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Abstract
Background—Hospital staff expressed health concerns after a surface disinfectant product 
containing hydrogen peroxide, peracetic acid, and acetic acid was introduced. We sought to 
determine if this product posed a health hazard.
Methods—An interviewer-administered questionnaire on work and health characteristics was 
completed by 163 current staff. Symptoms that improved away from work were considered work-
related. Forty-nine air samples were taken for hydrogen peroxide, peracetic acid, and acetic acid. 
Prevalence ratios (PRs) were calculated using Poisson regression, and standardized morbidity 
ratios (SMRs) were calculated using nationally representative data.
Results—Product users reported higher prevalence of work-related wheeze and watery eyes than 
non-users (P < .05). Workers in the department with the highest air measurements had 
significantly higher prevalence of watery eyes (PR, 2.88; 95% confidence interval [CI], 1.18–7.05) 
than those in departments with lower air measurements, and they also had a >3-fold excess of 
current asthma (SMR, 3.47; 95% CI, 1.48–8.13) compared with the U.S. population.
Conclusions—This disinfectant product was associated with mucous membrane and respiratory 
health effects. Risks of mucous membrane irritation and asthma in health care workers should be 
considered in development of disinfection protocols to protect patients from hospital-acquired 
infections. Identification of optimal protocols that reduce worker exposures while maintaining 
patient safety is needed.
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Health care–associated infections (HAIs) remain a significant challenge to health care 
facilities in the United States. On any given day, approximately 1 in 25 hospital patients has 
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at least 1 HAI.1 One of the most significant challenges to preventing HAIs is Clostridium 
difficile bacteria, which has replaced methicillin-resistant Staphylococcus aureus as the most 
common cause of HAI.2 Hospitalized patients acquire C difficile by ingesting spores 
transmitted from other patients through health care workers or from contact with 
contaminated surfaces in hospital rooms.3,4 Eliminating C difficile spores in the hospital 
environment requires the use of disinfectants that are sporicidal. Sporicides that are effective 
at reducing the environmental burden of C difficile may also contain chemicals that cause 
health effects for cleaning staff and other hospital workers.
Several studies have identified cleaning as an occupational risk factor for asthma among 
health care workers.5–8 There are a number of chemicals in cleaning and disinfecting 
products that can cause or exacerbate asthma because of their sensitizing or irritant 
properties, including quaternary ammonium compounds, ethanolamines, chlorhexidine, 
glutaraldehyde, ortho-phthalaldehyde, hexachlorophene, and chloramine-T.9–17 In addition, 
dermatitis and other adverse skin effects have been reported among hospital cleaning 
workers.18 However, some health care workers may underestimate their exposure or may 
lack knowledge of product components.19 There is no national surveillance of health effects 
related to cleaning and disinfection product use. In 4 states with occupational health 
surveillance, a total of 401 acute illnesses associated with work-related antimicrobial 
pesticide exposures in health care facilities were reported during 2002–2007. The most 
commonly reported health effects were eye irritation (55%), headaches or other neurologic 
symptoms (32%), respiratory symptoms (30%), and skin problems (24%). Among these 
reports, environmental service staff (EVS), who are largely responsible for cleaning and 
disinfection in health care facilities, was the most common occupation reporting health 
effects at 24%.20
In January 2015, the Centers for Disease Control and Prevention’s National Institute for 
Occupational Safety and Health (NIOSH) was notified through their Health Hazard 
Evaluation program of eye, respiratory, and skin problems among hospital EVS staff thought 
to be related to disinfectant use in a hospital. The hospital had introduced a new disinfectant 
product containing hydrogen peroxide, peracetic acid, and acetic acid in March 2014 to 
mitigate HAIs. We conducted a health hazard evaluation to assess if this disinfectant posed a 
health hazard to EVS and other hospital staff.
METHODS
An interviewer-administered questionnaire was offered to all EVS staff and an equal number 
of non-EVS staff on duty during the days of our visits. Non-EVS staff were recruited from 
the same departments of the hospital where EVS staff were located. Questions addressed 
self-reported respiratory and dermatologic symptoms, asthma and other diagnoses, smoking 
history, work history and practices, and demographic information. Participants ever having 
asthma were defined as those who were ever told by a physician or health care provider that 
they had asthma. Current asthma was defined as physician-diagnosed asthma that was still 
present. Some of these questions were taken from the Third National Health and Nutrition 
Examination Survey21 and the European Community Respiratory Health Survey.22 Asthma-
like symptoms were defined as a response of yes to any of the following questions22:
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1. Are you currently taking any medicine (including inhalers, aerosols, or tablets) 
for asthma?
2. Have you had wheezing or whistling in your chest at any time in the last 12 
months?
3. Have you woken up with a feeling of tightness in your chest at any time in the 
last 12 months?
4. Have you been woken by an attack of asthma at any time in the last 12 months?
Symptoms that improved when the employees were away from work, either on their days off 
or when they were on vacation, were considered work-related.
We collected 49 full-shift air samples from the breathing zones of EVS staff while they 
performed their regular cleaning duties. Details of the air sampling and air sample results are 
reported in Hawley et al.23 All air samples were analyzed for the 3 chemicals found in the 
disinfectant: hydrogen peroxide, peracetic acid, and acetic acid.
Statistical analyses were conducted using SAS software version 9.3 (SAS Institute, Cary, 
NC). Statistically significant differences between demographic characteristics, symptoms, 
and diagnoses were assessed using Student t test for continuous variables and χ2 test for 
categorical variables. We used Fisher exact test when cell sizes were <5. We considered 
results to be statistically significant when P = ≤.05 using a 2-sided test, and 95% confidence 
intervals were calculated.
Incidence densities of self-reported adult-onset asthma diagnosed by a physician before and 
after hire at the hospital were estimated using birth date, hire date, and diagnosis date. 
Asthma incidence density before hire was calculated by adding the number of adult-onset 
asthma diagnoses that occurred before hire and dividing by the sum of participants’ years at 
risk before hire. Asthma incidence density after hire was calculated by adding the number of 
adult-onset asthma diagnoses that occurred after hire and dividing by the sum of 
participants’ time at risk after hire. An incidence density ratio was calculated using Poisson 
regression.
We compared the observed prevalence of shortness of breath, cough, wheeze, watery eyes, 
and doctor-diagnosed asthma among participants to expected values for the general U.S. 
adult population obtained from the Third National Health and Nutrition Examination Survey. 
For these comparisons, we calculated standardized morbidity ratios (SMRs) using indirect 
standardization for race (white, black, or Mexican-American), sex, age (17–39 years or ≥40 
years), and cigarette smoking status (ever vs never smoker).21
Among the participants who worked in a department where air sampling was performed, we 
evaluated associations between symptoms and department-level air measurements by 
calculating prevalence ratios using Poisson regression. Concentrations of hydrogen peroxide, 
peracetic acid, and acetic acid from personal air samples were used in the American 
Conference of Governmental Industrial Hygienists’ (ACGIH) additive mixture formula. We 
used this formula to categorize departments by their total mixture of hydrogen peroxide, 
peracetic acid, and acetic acid.24 This formula takes the measured parts per million (ppm) 
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concentrations of hydrogen peroxide and acetic acid and divides them by their established 
Occupational Safety and Health Administration (OSHA) permissible exposure limits (PELs) 
and NIOSH recommended exposure limits (RELs) of 1 ppm for hydrogen peroxide and 10 
ppm for acetic acid. Measured ppm concentrations of peracetic acid were divided by the 
occupational exposure limits proposed by multiple researchers, of 0.2 ppm.25–27 Hydrogen 
peroxide [HP], peracetic acid [PAA], and acetic acid [AA] represent the measured full-shift 
time weighted average. ACGIH mixture formula results <1 are considered to be below the 
threshold limit value where adverse effects may occur.
The mixture values derived from the formula were averaged using arithmetic means 
calculated by the hospital department where the survey participant was assigned. Based on 
this department-level value of the ACGIH mixture formula, 9 departments were categorized 
into tertiles of low (≤0.075), medium (>0.075 to ≤0.190), and high (>0.190) exposure 
categories. Prevalence ratios were calculated by comparing the single department with the 
highest ACGIH value, departments in the high category, and departments in the medium 
category to departments in the low category.
RESULTS
A total of 163 current employees, including 78% (n = 79/101) of EVS staff who were 
working on the days of the survey, completed the questionnaire. Five EVS staff refused to 
participate. Hospital supervisors and charge nurses assisted in pulling non-EVS staff from 
their duties to participate in the survey. As a result, there were no non-EVS staff who refused 
to participate. Non-EVS staff included nursing staff (n = 27); other patient care staff (n = 
25), such as patient care technicians, respiratory therapists, and nursing assistants; 
administrative staff (n = 13), such as business managers and unit clerks; and other hospital 
staff (n = 19), such as cooks, dietitians, and laboratory staff. Table 1 describes the 
demographic and work characteristics of questionnaire participants.
EVS staff represented 48% (n = 79/163) of questionnaire participants. EVS and Non-EVS 
staff were similar regarding age, tenure, and smoking status. Men were significantly (P < .
05) more represented among EVS staff than non-EVS staff, representing roughly half (49%, 
n = 39/79) of EVS participants. Most non-EVS staff were white (85%, n = 71/84), whereas 
most EVS staff were black (59%, n = 47/ 79). Differences in race were statistically 
significant (P < .05) (Table 1).
Although most EVS staff were users of the disinfectant product containing hydrogen 
peroxide, acetic acid, and peracetic acid, 11 (14%, n = 11/79) indicated that they did not use 
the disinfectant. Ten (12%, n = 10/84) non-EVS staff members indicated that they used the 
disinfectant. Disinfectant users and nonusers were similar regarding age, tenure, and 
smoking status. Disinfectant users were significantly (P < .05) more likely to be men than 
disinfectant nonusers, with 42% of disinfectant users being men. Black participants were 
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more represented among disinfectant users, representing 53% (n = 41/ 78) of disinfectant 
users and 19% (n = 16/85) of disinfectant nonusers. Seventy-eight percent (n = 66/85) of 
disinfectant nonusers were white. This difference in race was statistically significant (P < .
05) (Table 1).
The most commonly reported symptoms among all participants were nasal problems, such 
as rhinitis, (42%, n = 68/163) and watery eyes (40%, n = 65/163) (Table 2). Other commonly 
reported symptoms included asthma-like symptoms (28%, n = 46/ 163), skin problems 
(19%, 31/163), and wheeze (16%, n = 26/163). The prevalence of shortness of breath, 
cough, wheeze, and eye symptoms were not significantly different than the expected 
prevalence for the U.S. adult population (data not shown). A number of reported symptoms 
were described to be work-related, including 61% (n = 19/ 31) of skin problems, 50% (n = 
4/8) of asthma attacks, 48% (n = 31/ 65) of watery eyes, 44% (n = 4/9) of cough, and 43% (n 
= 29/68) of nasal problems. Use of allergy medication was reported by 29% (n = 48/163) of 
participants.
Among the 68 employees who said they had nasal problems, 50% (n = 34/68) said that 
something at work brought on or made their nasal problems worse. Of those, 50% (n = 
17/34) specified that the disinfectant product brought on or made their nasal problems 
worse. Fifty-two percent (n = 34/65) reported that something at work brought on or made 
their watery eye symptoms worse, and among those, 68% (n = 23/34) specified the 
disinfection product. Fifty-three percent (n = 9/17) of staff who reported that something at 
work brought on or made their skin problems worse specified the disinfection product.
Twenty percent (n = 32/163) of participants reported ever being diagnosed with asthma 
(Table 2), which was 2.4 times higher (SMR, 2.4; 95% CI, 1.6–3.4) than expected when 
compared with the U.S. adult population. Current asthma was reported by 14% (n = 23/ 163) 
of participants and was 2.3 times higher (SMR, 2.3; 95% CI, 1.5–3.6) than expected for the 
U.S. adult population. A total of 15 (9%, n = 15/163) participants described asthma that met 
the definition for adult-onset asthma. The prehire adult-onset asthma incidence density was 
4.8 cases per 1,000 person years. The posthire adult-onset asthma incidence density was 5.5 
cases per 1,000 person years; these incidence densities were not significantly different. 
Similarly, we evaluated the asthma incidence densities before and after the introduction of 
the disinfection product; these incidence densities were also not significantly different.
A comparison of health symptoms between disinfectant product users and nonusers can be 
seen in Table 2. Use of allergy medication and self-reported doctor diagnosis of nasal 
allergies were significantly less common among disinfectant product users than nonusers (P 
< .05). There were no other significant differences between disinfectant product users and 
nonusers. No significant associations were found between the prevalence of health effects 
and other hospital cleaning products (results not shown).
Comparing disinfectant users and nonusers who reported symptoms, some symptoms were 
described to be work-related. Figure 1 shows that disinfectant product users reported higher 
prevalence of work-related watery eyes, nasal problems, asthma-like symptoms, wheeze, 
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shortness of breath, use of asthma medicine, cough, chest tightness, and asthma attack, with 
statistically significant differences for wheeze and watery eyes (P < .05).
Health effects and air measurements
There were 85 survey participants who worked in 9 departments where air sampling was 
performed. These departments included labor and delivery (n = 28), a neonatal intensive care 
unit (n = 18), an outpatient clinic (n = 4), 2 antepartum-postpartum units (n = 14), 2 medical-
surgical units (n = 11), an oncology unit (n = 5), and an intensive care unit (n = 5). All air 
measurements for hydrogen peroxide and acetic acid were below their respective OSHA 
PELs.27 There is currently no established PEL or REL for peracetic acid. The labor and 
delivery department had the highest average measurements of all 3 chemicals: 168.7 ppb for 
hydrogen peroxide, 25.0 ppb for peracetic acid, and 249.8 ppb for acetic acid. This 
department also had the highest average ACGIH mixture result. ACGIH mixture formula 
results for all departments were well below the threshold value level of 1. ACGIH mixture 
categories were comprised of the following departments: low (outpatient clinic at 0.055, 
medical-surgical unit at 0.064, and postpartum-antepartum unit at 0.075), medium (intensive 
care unit at 0.151, oncology unit at 0.151, and postpartum unit at 0.188), and high (neonatal 
intensive care unit at 0.192, a medical-surgical unit at 0.246, and labor and delivery unit at 
0.315).
Prevalence ratios comparing the labor and delivery department, departments with high 
ACGIH mixture formula results, and departments with medium ACGIH mixture formula 
results with the departments with low formula results are in Figure 2. Statistically significant 
results were found for watery eyes in the labor and delivery department (prevalence ratio, 
2.88; 95% CI, 1.18–7.05) and departments with high ACGIH mixture formula results 
(prevalence ratio, 2.58; 95% CI, 1.07–6.26) when compared with departments with low 
ACGIH mixture formula results.
We compared the prevalence of shortness of breath, cough, wheeze, watery eyes, and asthma 
diagnosis among workers in the labor and delivery department with the U.S. adult 
population. The prevalence of watery eyes (SMR, 1.70; 95% CI, 1.06–2.72), lifetime asthma 
diagnosis (SMR, 2.50; 95% CI, 1.07–5.85), and current asthma (SMR, 3.47; 95% CI, 1.48–
8.13) was significantly higher than expected when compared with the U.S. adult population. 
Prevalence of watery eyes and current asthma among workers in all other departments where 
air sampling was performed was not significantly higher than expected. However, lifetime 
asthma diagnosis was significantly higher than expected (SMR, 2.52; 95% CI, 1.41–4.51) in 
these other departments.
DISCUSSION
We found a higher prevalence of work-related wheeze and watery eyes among users of the 
disinfectant product. Among workers who reported that something at work brought on or 
made their nasal symptoms worse, half stated that the disinfectant product brought on or 
made their symptoms worse. The types of symptoms reported by staff in our survey were 
similar to the symptoms reported in a 2007 case study that described cough, wheezing, and 
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shortness of breath among 2 endoscopy nurses exposed to a mixture of peracetic acid and 
hydrogen peroxide.28
We also found a higher prevalence of several health effects among product users and 
nonusers working in the labor and delivery department, which had the highest mixture of 
chemicals found in the disinfectant product. The prevalence of watery eyes and current 
asthma in this department, but not other departments, was significantly higher than what 
would be expected for the U.S. adult population. Higher air measurements in labor and 
delivery were consistent with our observation of increased frequency and duration of 
cleaning tasks, described in the NIOSH report23 The labor and delivery department had short 
patient stays, requiring consecutive terminal cleaning of rooms to accept new admissions.
The prevalence of asthma in this hospital was significantly higher than what would be 
expected when compared with the U.S. adult population. We did not find a significant 
difference in the prevalence of asthma among disinfectant users when compared with 
nonusers. Several case studies have described new onset asthma or asthma exacerbations 
among individuals who encounter cleaning and disinfecting chemicals through the air in 
their work environment, but do not use these products.9,29 The bystander effect, whereby 
nonproduct users are exposed to vapors from cleaning products, may explain why we saw no 
significant differences in asthma prevalence between product users and nonusers, a large 
asthma burden overall in this facility, and increases in health effects in departments with 
higher measures of cleaning chemicals in the air.
There are a number of limitations to our study. Survey participants were asked which 
cleaning and disinfection products they used using an inventory of all known cleaning 
products in the hospital. Although we did not find significant results between other products 
and health effects, air samples for other cleaning chemicals such as quaternary ammonium 
compounds were not taken. At the time of our survey, no effective air sampling method for 
quaternary ammonium compounds had been developed, and our observations during air 
sampling showed that the disinfectant product was being used as the primary disinfectant for 
most surfaces throughout the hospital, and use of other products was less frequent.23 We also 
relied on self-reports of health concerns and whether symptoms were work-related, which 
may be subject to recall or reporting bias. In addition, the cross-sectional nature of our 
evaluation makes it difficult to determine temporal relationships between health effects and 
use of the disinfectant; however, anecdotally, reports of symptoms increased after the 
product was introduced at the hospital. Finally, the questionnaire was administered to current 
workers only. These workers might have been healthier than all workers who had ever been 
employed at the facility because workers who were too ill to work might have resigned, 
possibly resulting in an underestimation of symptoms and diagnoses.
In 2015, this disinfectant product was listed as an asthmagen, or a substance that causes 
asthma, by the Association of Occupational and Environmental Clinics.30 Although the air 
measurements were well below the OSHA PEL and ACGIH mixture threshold, we did 
observe increased health effects in the departments with higher measures of chemicals in the 
air. For this reason, exposure reduction should be considered even when chemicals are 
measured at low levels. In 2008, the Centers for Disease Control and Prevention’s 
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Healthcare Infection Control Practices Advisory Committee (HICPAC) developed 
“Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008.”31 This 
guideline acknowledges that occupational diseases among cleaning personnel have been 
associated with disinfectant use at levels below OSHA or NIOSH exposure limits. HICPAC 
recommends that controls be used to minimize exposure to disinfectants, including 
elimination or substitution of the chemical, engineering or administrative controls, or use of 
personal protective equipment.
Although cleaning and disinfecting agents are an important part of reducing HAIs, these 
products must be used judiciously and used in a way that reflects the level of risk in 
acquiring an HAI. HICPAC states that detergent and water are adequate for cleaning 
surfaces in nonpatient care areas. We recommend that the disinfectant product not be used in 
nonpatient care areas, which may include public bathrooms or administrative o3ces. It is 
also important for employees to report any symptoms they feel are related to their work so 
controls may be put into place to reduce worker exposure. Implementing a reporting system 
for employees to report work-related symptoms directly to occupational health staff, with the 
option to remain anonymous, may help facilitate this communication. HICPAC recommends 
this measure as a performance indicator for disinfection and sterilization.31 For those 
workers experiencing work-related health effects associated with cleaning or disinfection 
products, occupational health staff should develop policies and practices that would allow 
these workers to be reassigned to an area with less disinfectant exposure. Finally, it is 
important that employees understand the potential hazards from exposure to cleaning 
products and how to protect themselves. HICPAC recommends that each worker be 
informed of the possible health effect(s) of his or her exposure to chemicals.31 These 
recommendations may help to address worker concerns regarding cleaning and disinfection 
products and encourage communication regarding occupational illness.
CONCLUSIONS
Some infection control practices that require the use of products containing hydrogen 
peroxide, peracetic acid, and acetic acid may result in adverse health effects in exposed 
workers. HAIs remain a significant threat to patient safety, and environmental cleaning and 
disinfection is a key aspect in a comprehensive HAI prevention plan. However, by taking 
worker concerns about occupational illness seriously and implementing controls to reduce 
exposure to cleaning and disinfection products, health care facilities may provide a safer 
environment for workers while protecting patients from HAIs. This study highlights the 
importance of considering disinfectant exposure when evaluating health care workers for 
occupational illness. More research is needed to characterize product exposure, associated 
health effects, and control methods.
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Prevalence of work-related symptoms by disinfectant product use at a hospital, August 2015. 
Work-related symptoms were defined as symptoms that improved away from the facility, 
either on days off or on vacation. *Statistically significant differences using χ2 test (P < .
05). †All symptoms specific to the last 12 months.
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Prevalence ratios and 95% confidence intervals comparing the labor and delivery 
department, departments with high and medium ACGIH mixture formula results, and 
departments with low ACGIH mixture formula results. *Statistically sig-nificant results. 
†All symptoms specific to the last 12 months. §Asthma-like symptoms, defined as current 
use of asthma medicine or ≥ 1 of the following symptoms in the last 12 months: wheezing or 
whistling in the chest, awakening with a feeling of chest tightness, or attack of asthma. 
ACGIH, American Conference of Governmental Industrial Hygienists
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